Stable oral CI-981 formulation and process for preparing same
US6126971A · kind A · utility
25Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 1997 |
| Grant date | Oct 3, 2000 |
| Priority date | — |
| Expiry date | Jul 2, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA) ##STR1## with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.